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        NK cells are an important component of innate 
immunity, capable of mediating cytotoxicity 
against tumor and virus-infected cells. Eff  ector 
functions of NK cells are regulated by the coor-
dinated interaction of activating and inhibitory 
receptors (  1  ). Determining precise signaling 
events downstream of these receptors is para-
mount for successful clinical utilization of NK 
cells. One of the activating receptors, NKG2D, 
is a lectin type II transmembrane protein ex-
pressed on all human and mouse NK cells, and it 
recognizes MIC-A/B (  2  ) and ULBP-1/2/3 (in 
humans) (  3  ), and H60 (  4, 5  ), Rae-1     /     /     /     /      
(  5  ), and Mult-1 (in mice) (  6  ). Upon activation, 
NKG2D employs Src family protein tyrosine 
kinases (PTKs) to initiate two distinct signaling 
pathways (  7  –  11  ), leading to eff  ector functions. 
In the fi  rst pathway, activated PTK phosphor-
ylates Tyr-Ile-Asn-Met (YINM) motif-bearing 
DAP10, which in turn recruits phosphatidyl-
inositol 3-kinase (PI3K) ( 9  ). In the second path-
way, PTK phosphorylates the immunoreceptor 
tyrosine-based activation motif (ITAM)  –  con-
taining KARAP/DAP12, which subsequently 
triggers Syk and ZAP70 (  8  –  11  ). Another major 
activating receptor, Ly49D, which associates 
with both DAP10 and DAP12 (  12, 13  ), is also 
a mouse lectin type II transmembrane pro-
tein, which interacts with classical MHC class 
I, H2-D  d   (  14  ). 
  Natural cytotoxicity receptors (NCRs) are 
immunoglobulin-like transmembrane glyco-
proteins that recognize unknown ligands on 
several tumor cells. The NCR family contains 
three human (NKp46/NCR1, NKp44/NCR2, 
and NKp30/NCR3) and one mouse (NKp46/
NCR1) members (  15  –  18  ). NKp46 and NKp30 
associate with ITAM-bearing CD3      (  17  ) and 
FCR      (  19  ), respectively, whereas NKp44 re-
cruits DAP12 (  20  ). Although cellular ligands 
for NCRs have not been found, NCR1 is 
known to interact with hemagglutinin (HA) of 
infl  uenza and HA-neuraminidase of Sendai 
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  Phosphatidylinositol 3-kinases (PI3Ks) play a critical role in regulating B cell receptor  –   and 
T cell receptor  –  mediated signaling. However, their role in natural killer (NK) cell develop-
ment and functions is not well understood. Using mice expressing p110      D910A  , a catalyti-
cally inactive p110    , we show that these mice had reduced NK cellularity, defective Ly49C 
and Ly49I NK subset maturation, and decreased CD27  High   NK numbers. p110     inactivation 
marginally impaired NK-mediated cytotoxicity against tumor cells in vitro and in vivo. 
However, NKG2D, Ly49D, and NK1.1 receptor  –  mediated cytokine and chemokine genera-
tion by NK cells was severely affected in these mice. Further, p110      D910A/D910A   NK cell  –
  mediated antiviral responses through natural cytotoxicity receptor 1 were reduced. 
Analysis of signaling events demonstrates that p110      D910A/D910A   NK cells had a reduced c-
Jun N-terminal kinase 1/2 phosphorylation in response to NKG2D-mediated activation. 
These results reveal a previously unrecognized role of PI3K-p110     in NK cell development 
and effector functions. 
© 2008 Guo et al.  This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the fi  rst six months 
after the publication date (see http://www.jem.org/misc/terms.shtml). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons
.org/licenses/by-nc-sa/3.0/).2420 PI3K-P110      REGULATES NK CELL MATURATION AND FUNCTION   | Guo et al. 
    RESULTS   
  Unaltered expression of PI3K subunits 
in p110      D910A/D910A   mice 
  The class I PI3K complex is primarily made up of p85 regula-
tory and p110 catalytic subunits. Altering expression of one 
subunit severely aff  ects the expression of the others (  31  ). p110      
deletion resulted in signifi  cant overexpression of the p85      sub-
unit (  33  ). Similarly, deletion of p85      leads to an increased ex-
pression of p85      and a dramatic decrease of p110     , p110     , and 
p110      subunits (  28, 29  ). Therefore, we fi  rst analyzed the ex-
pression of distinct PI3K subunits in IL-2  –  activated NK cells 
from p110       D910A/D910A   mice that were backcrossed with the 
C57BL/6 strain for N12 generations (  Fig. 1 a  ).   All p110 iso-
forms were detectable in NK cells derived from both spleen and 
BM, with the level of the inactive p110      being similar to that 
in NK cells from C57BL/6 (WT/WT) mice. No compensa-
tory expressions of p110     , p110     , and p110      in NK cells from 
spleen and BM of p110       D910A/D910A   mice were found. We also 
analyzed the presence of total p85 and p85      subunits with pan  –
  anti-p85 and anti-p85      antibodies, respectively. Our results 
showed no alteration in the quantity of total p85 or p85      sub-
unit in p110       D910A/D910A  -derived splenic or BM NK cells (  Fig. 
1 a  ). These observations are consistent with our earlier studies, 
which demonstrated that thymocytes from p110       D910A/D910A   
mice contain similar expression levels of p110     , p110     , and 
total p85 subunits compared with those of WT mice (  32  ). Col-
lectively, we conclude that the D910A mutation did not alter 
the protein expression levels of p110      itself. Also, there were 
no alterations in the protein levels of p110     , p110     , and p110      
subunits in the NK cells from p110       D910A/D910A   mice. Further, 
there were no changes in the levels of total p85 or p85      sub-
units because of the D910A mutation. 
  p110     regulates cellularity but not NK cell commitment 
  To defi  ne the role of p110      in early NK cell development, we 
analyzed the cell numbers. Total cellularity of both spleen and 
BM was signifi  cantly reduced in p110      D910A/D910A   mice ( Fig. 1 b ). 
Concurrently, the absolute numbers of the CD3        NK1.1  +   
NK cell population were also reduced in the spleen of 
p110       D910A/D910A   mice (  Fig. 1 c  ). The numbers of BM-derived 
CD3        NK1.1  +   NK cells were slightly reduced (  Fig. 1 c  ). Re-
cent studies have demonstrated that the process of NK cell 
development can be defi  ned into fi  ve distinct stages based on 
the expression pattern of cell-surface markers (  34  ). Expression 
of CD122, which is the       chain of IL-2 and IL-15 receptors, 
marks the commitment of progenitor cells into the NK lineage 
in the BM. NKG2D and NK1.1 are the earliest known NK 
markers ( 35  ). Integrins such as CD11b (Mac-1) and CD43 (leu-
kosialin), which can regulate lymphocyte migration and hom-
ing, are up-regulated, whereas CD51 (       v  ) expression declines 
during the fi  nal maturation stage (  34  ). To determine whether 
functional inactivation of p110      could aff  ect the maturation of 
NK cells, we analyzed the expression of developmental mark-
ers on fresh NK cells derived from BM (  Fig. 1 d  ) and spleen 
(Fig. S1, available at http://www.jem.org/cgi/content/full/
jem.20072327/DC1). Gated CD3        NK1.1  +   NK cells were 
virus (  21  ). NK1.1 (Nkrp1c) is a unique cell marker expressed 
on NK and NKT cells (  22  ). Although the activating ligands 
for Nkrp1c have yet to be determined, the inhibitory ligands 
for its related family members Nkrp1d and Nkrp1f have been 
defi  ned as the Clr family of C-type lectins (  23  ). NK1.1 physi-
cally associates with FcR      to mediate its signal (  24  ). Several 
NK inhibitory receptors have been identifi  ed, such as KIR, 
Ly49A, Ly49C, Ly49G2, and Ly49I (  25  ). These inhibitory 
receptors recognize classical MHC class I molecules. Upon in-
teraction, they recruit phosphatases to the immunoreceptor ty-
rosine-based inhibitory motif in the cytoplasmic domains (  26  ). 
Thus, NK cells use a complex set of receptors and signaling 
pathways to achieve their intended eff  ector functions. Despite 
recent studies (  8  –  13  ) that have provided deeper insights re-
garding the activation pathways, multiple knowledge gaps ex-
ist, hindering comprehensive clinical applications of NK cells. 
  Class I PI3Ks generate secondary lipid messengers that 
regulate a wide array of intracellular signaling pathways in 
numerous cell types (  27  ). Several isoforms of regulatory p85 
(p85     , p55     , p50     , p85     , and p55     ) and catalytic p110 
(p110     , p110     , p110     , and p110     ) subunits have been de-
scribed to play distinct functions (  27  ). For example, mice 
lacking the p85      regulatory or p110      catalytic subunit show 
severely impaired B and T cell development and functions 
(  28, 29  ). Deletion of individual catalytic or regulatory sub-
units results in altered expression of other subunits (  30, 31  ). 
Thus, use of gene KO mice precludes proper evaluation of 
the PI3K isoform-selective functions in lymphocytes. To 
avoid these inherent complications in using KO mice, we 
generated mice with a point mutation that completely inacti-
vated the catalytic function of p110      subunit (further referred 
to as p110       D910A/D910A   mice) (  32  ). This point mutation, 
Asp  910    →  Ala (D910A), resulted in a complete loss-of-function 
locus but retained the normal expression levels of p110      pro-
tein. More importantly, this strategy did not result in any 
compensatory increase of p110     , p110     , and total p85 sub-
units in thymocytes (  32  ). 
  In this study, using the p110       D910A/D910A   mice, we demon-
strate that PI3K-p110      plays a pivotal role in the development 
and eff  ector functions of NK cells. p110       D910A/D910A   mice had 
reduced NK cellularity and a selective impairment in the matu-
ration of Ly49C and Ly49I NK subsets. Further, mature NK 
cell populations, as defi  ned by CD27 and CD11b, were mark-
edly altered in p110       D910A/D910A   mice. p110      inactivation mar-
ginally impaired NK cell  –  mediated cytotoxicity against tumor 
and virally infected cells. However, NKG2D, Ly49D, and 
NK1.1 receptor  –  mediated cytokine and chemokine generation 
were severely impaired in NK cells from p110       D910A/D910A   
mice. In addition, cytokine generation by p110       D910A/D910A   NK 
cells in response to virally infected cells was markedly reduced. 
Biochemical analysis indicates that defects in the activation and 
phosphorylation of the c-Jun N-terminal kinase (JNK) pathway 
could be responsible for the impaired cytokine generation in 
p110       D910A/D910A   NK cells. Our results demonstrate that the 
PI3K-p110      subunit plays a crucial role in NK cellularity, ter-
minal maturation, and cytokine/chemokine generation. JEM VOL. 205, September 29, 2008 
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other Ly49 receptors, and the adverse eff  ect of p110      mutation 
only aff  ected the maturation of Ly49C and Ly49I NK subsets. 
  Reduction in the absolute NK cell numbers and in Ly49C/I 
needs further explanation. PI3K-mediated signaling initiates 
key prosurvival pathways (  36  ). It is also important to note 
that only Ly49C/I receptors have the ability to recognize the 
self  –  MHC class I molecules, H2-K  b   and H2-D  b  . Expression 
of these MHCs are not altered because of the inactivation 
of p110     , arguing against one possible extrinsic eff  ect during 
NK maturation (Fig. S3, available at http://www.jem.org/
cgi/content/full/jem.20072327/DC1). Currently, we cannot 
exclude the potential possibility that p110     -mediated signaling 
is required for   “  licensing  ”   (  37  ) or   “  arming  ”   (  38  ). In the ab-
sence of p110     , either the rate of NK cell proliferation or cell 
survival could have been altered. To diff  erentiate between 
these two possibilities, spleen-derived IL-2  –  activated NK cells 
were labeled with BrdU to analyze their proliferation. Results 
presented in   Fig. 3 (a  –  c)   demonstrate that the overall percent-
ages of proliferating p110       D910A/D910A   NK cells were signifi  -
cantly reduced.   In particular, proliferation of Ly49C/I subsets 
were more severely impaired (P = 0.0096) than other Ly49 
subsets. To determine the role of apoptosis in the reduction of 
Ly49C/I subsets, NK cells were cultured with IL-2 for 6 d, 
and individual subsets were analyzed with 7-aminoactinomycin 
D (7-AAD) and Annexin V staining. Our data indicate that 
analyzed for the expression of CD122, NKG2D, NKG2A, 
CD11b, CD244, CD43, CD49b, and CD51. Expression lev-
els of CD122, NKG2D, NKG2A, CD11b, and CD244 were 
unaff  ected in p110       D910A/D910A   mice (  Fig. 1 d  ). Inactivation of 
p110      also did not aff  ect the expression of CD49b, CD51, and 
CD43 in CD3        NK1.1  +   NK cells (  Fig. 1 d  ). Similar results 
were observed in IL-2  –  activated NK cells (Fig. S2, a and b). 
  p110     regulates the terminal maturation 
of Ly49C/I NK subsets 
  Acquisition of distinct Ly49 receptors by CD3        NK1.1  +   NK 
cells is an important developmental step by which the NK 
  “  repertoire  ”   is generated. Expression of Ly49C and Ly49I were 
severely impaired in the fresh NK cells from the BM and spleen 
of p110       D910A/D910A   mice (  Fig. 2, a and b  ).   However, expression 
of inhibitory Ly49A or Ly49G2 and activating Ly49D recep-
tors was unaff  ected by p110      inactivation in fresh NK cells 
(  Fig. 2, a and b  ). Analyses of IL-2  –  activated BM NK cells fur-
ther indicated the defective expression of Ly49C and Ly49I re-
ceptors (  Fig. 2 c  ). Similar to freshly isolated NK cells, the 
proportion of Ly49A, Ly49D, and Ly49G2 subsets remained 
unaff  ected in IL-2  –  activated BM NK cells (  Fig. 2 c  ). Compara-
ble results were observed in spleen-derived and IL-2  –  activated 
NK cells (  Fig. 2 d  ) from p110       D910A/D910A   mice. Thus, a reduc-
tion in Ly49C or Ly49I did not depend on the coexpression of 
    Figure 1.         Phenotypic characterization of p110      D910A/D910A   mice.   (a) Expression levels of PI3K subunits were unaltered after the catalytic inactivation 
of p110     . Expression of p110 and total p85 and p85      isoforms was analyzed by Western blotting in IL-2  –  activated splenic and BM NK cells. (b) Absolute 
numbers of spleen and BM cells are signifi  cantly reduced in p110     D910A/D910A   mice. Total cellularity of the spleen and BM was calculated from 10 mice in 
each genotype. (c) Absolute CD3       NK1.1 +   cell number is decreased in p110     D910A/D910A   mice. Single-cell suspensions were stained with anti-NK1.1 and anti-
CD3      mAbs. NK cells as specifi  ed by CD3       NK1.1 +   positivity were gated and analyzed for absolute numbers. Data shown were obtained using cells from 
seven mice of each genotype. (d) Expression of early developmental markers in fresh p110     D910A/D910A   BM NK cells. Percentages of positive NK cells for each 
marker among CD3       NK1.1 +   cells are shown. Gates were set using unstained or nonspecifi  c isotype mAb controls (not depicted). Data presented were 
means obtained from seven mice of each genotype. Data presented were means and standard deviations from three to fi   ve  experiments.   2422 PI3K-P110      REGULATES NK CELL MATURATION AND FUNCTION   | Guo et al. 
cells and analyzed for CD27 and CD11b markers.   Fig. 4   shows 
that a lack of functional p110      altered the ratio of CD27- and 
CD11b-expressing NK subsets.   There was a signifi  cant reduc-
tion in the CD27  High  CD11b  Low   NK cells in both fresh BM 
(  Fig. 4 a  ) and spleen (  Fig. 4 b  ) of p110       D910A/D910A   mice. The 
CD27  High  CD11b  High   NK cell numbers were also aff  ected in the 
spleen of p110       D910A/D910A   mice. More importantly, the de-
crease in the CD27  High  CD11b  High   population was correlated 
with a concomitant increase in the CD27  Low  CD11b  High   NK 
subsets in both fresh BM and spleen of the p110       D910A/D910A   
NK population. Earlier studies have also indicated a skewed 
expression of Ly49C/I receptors in CD27  Low  CD11b  high   NK 
cells (  39  ). Because we observed a specifi  c reduction in the 
Ly49C/I subsets in the absence of functional p110     , we ana-
lyzed the fresh NK cells from p110       D910A/D910A   mice for CD27 
and Ly49 expressions. Results presented in   Fig. 4 c   indicate 
that Ly49A, Ly49I, Ly49D, and Ly49G2 NK subsets with 
CD27  High   positivity were reduced more in p110       D910A/D910A   
NK cells than those of WT/WT. However, the reduction in 
the Ly49I  +  CD27  High   NK subset was more severe compared 
with other subsets in p110       D910A/D910A   NK cells. Based on these 
among NK cells from spleen (  Fig. 3 d  ), there was a consistent, 
signifi  cant but minimal increase of Annexin V  –  positive Ly49 
subsets from p110       D910A/D910A   mice (  <  10% of the total ana-
lyzed). However, no major changes were seen between BM-
derived WT/WT and p110       D910A/D910A   NK cells (Fig. S4). 
These results indicate that a lack of p110      most probably aff  ects 
the proliferative rate of NK cells and that the eff  ect on their 
survival is minimal. 
  CD27  High  CD11b  High   NK populations are severely reduced 
in p110      D910A/D910A   mice 
  Recent studies have shown that the mature CD11b  +   NK cells 
can be further divided into CD27  High   and CD27  Low   with dis-
tinct functional abilities (  39  –  41  ). These studies demonstrate 
that CD27  High  CD11b  High   NK cells were superior in their abil-
ity to lyse target cells compared with that of CD27  Low  CD11b  High   
cells. Further, CD27  High  CD11b  High   NK cells produced consid-
erably higher amounts of IFN-      (  39  ). Because NK cells from 
p110       D910A/D910A   mice showed a specifi  c defect in Ly49C/I ex-
pression, we extended our analyses to CD27-based NK matu-
ration. Fresh BM and splenocytes were gated for CD3        NK1.1  +   
    Figure 2.         Catalytic inactivation of p110     results in impaired maturation of Ly49C and Ly49I NK subsets.   Expression of maturation markers on 
p110     D910A/D910A   NK cells was analyzed by fl  ow cytometry. Percentages of Ly49C/I  +   NK subset are signifi  cantly reduced on both fresh BM (a) and splenic (b) 
p110     D910A/D910A   NK cells. Percentages of Ly49C/I  +   or  Ly49I +   NK subset are signifi  cantly reduced in the IL-2  –  activated BM (c) or splenic (d) p110     D910A/D910A  
NK cells that were stained with anti  –  Ly49C/I-PE or anti  –  Ly49I-PE mAbs in combination with anti  –  Ly49G2-allophycocyanin, or anti  –  Ly49A-PE in combina-
tion with anti  –  Ly49D-FITC mAbs. Percentages of each NK subset are shown. NK cells from seven (a and b) or three (c and d) mice of each genotype were 
used. Data shown were obtained from three to fi  ve independent experiments.     JEM VOL. 205, September 29, 2008 
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cytotoxic potential of p110       D910A/D910A   NK cells was margin-
ally reduced (  Fig. 5 a  ).   Similar to fresh NK cells, IL-2  –  acti-
vated splenic p110       D910A/D910A   NK cells also had a reduced 
ability to lyse EL4  H60   compared with WT/WT NK cells (  Fig. 
5 b  ). As expected, there is only a minimal lysis of EL4 by ei-
ther IL-2  –  activated WT/WT or p110       D910A/D910A   NK cells 
(  Fig. 5 b  ). This cytotoxicity response directed to EL4  H60   was 
primarily mediated through the NKG2D receptor, because an 
anti-NKG2D mAb (C7) abrogated this response in both WT/
WT and p110       D910A/D910A   NK cells (Fig. S5, available at 
http://www.jem.org/cgi/content/full/jem.20072327/DC1). 
Another tumor cell line, YAC-1, which naturally expresses 
H60, was also lysed less by p110       D910A/D910A   NK cells (  Fig. 5 b  ). 
results, we conclude that p110      is needed for both Ly49C/I 
subset specifi  cation and proliferation, and CD27  High  CD11b  High   
NK maturation. 
  Cytotoxicity is marginally impaired 
in p110      D910A/D910A   NK cells 
  A detailed analysis of the role of PI3K and its subunits in regu-
lating   “  induced-self  ”   and   “  missing-self  ”   recognition is lack-
ing. Therefore, we evaluated the ability of p110       D910A/D910A   
NK cells to mediate cytotoxicity toward several tumor targets 
in   51  Cr-release assays. Fresh NK cells were purifi  ed from sple-
nocytes and were tested for their ability to mediate the lysis of 
EL4  H60   target cells (  42, 43  ). Compared with WT/WT, the 
    Figure 3.         Defective proliferation but not increased apoptosis affects the Ly49C/I NK subsets in p110      D910A/D910A   mice.   IL-2 – cultured  splenic  NK 
cells were pulsed with BrdU as in Materials and methods. 4 h later, NK cells were stained and analyzed for Ly49A (a), Ly49C/I (b), and Ly49G2 (c) subset 
proliferation. The percentages of BrdU-positive and -negative Ly49 subsets are also shown as histograms (a  –  c, right). Data presented are mean values 
from three mice of each genotype. (d) IL-2  –  cultured splenic NK cells were stained with Annexin V and 7-AAD for apoptosis analysis of each Ly49 NK sub-
set. Data presented are mean values from three mice of each genotype. One representative of three independent experiments is shown.   2424 PI3K-P110      REGULATES NK CELL MATURATION AND FUNCTION   | Guo et al. 
sets are severely decreased and total numbers of spleen and BM 
cells are signifi  cantly reduced in p110       D910A/D910A   mice, sorting 
enough Ly49C/I single-positive NK subsets is diffi   cult. There-
fore, we pooled Ly49C/I single-positive and Ly49C/I, Ly49G2 
double-positive NK subsets (Ly49C/I  +  Ly49G2    ±   ) for the   51  Cr-
release assay. Cytotoxicity of Ly49C/I  +  Ly49G2    ±    NK subsets 
from p110       D910A/D910A   mice (  Fig. 5 c  ) was relatively more im-
paired compared with sorted Ly49C/I        Ly49G2  +   (  Fig. 5 d  ) 
and Ly49C/I        Ly49G2         (  Fig. 5 e  ) NK subsets. Nevertheless, 
these results for the fi  rst time demonstrate a preferential re-
quirement of p110      by Ly49C/I NK subsets for cytotoxicity. 
  Next, we evaluated the ability of p110       D910A/D910A   mice 
to clear in vivo tumor growth. Toward this, WT/WT and 
p110       D910A/D910A   mice were challenged with RMA and RMA/
S cells. These tumor cells were labeled with CFSE or SNAF 
and were injected in combinations into the intraperitoneal 
cavity; 6 h later, peritoneal exudates were collected and ana-
lyzed for the level of tumor clearance and NK cell accumulation. 
Similar observations were made using BM-derived NK cells 
(unpublished data). Cells that lack or have reduced expression 
of self  –  MHC class I molecules are susceptible to NK-medi-
ated cytotoxicity (  44  ). As seen in   Fig. 5 b  , p110       D910A/D910A   
NK cells showed reduced cytotoxicity against RMA/S cells, 
which express lower levels of MHC class I. To test whether 
p110      plays a role in Ly49D-mediated cytotoxicity, we used 
Chinese hamster ovary (CHO) cells that express a hamster 
homologue of H2-D  d   (  14  ). As shown in   Fig. 5 b  , spleen-de-
rived, IL-2  –  activated p110       D910A/D910A   NK cells had reduced 
lysis against CHO cells. 
  Because the terminal maturation of Ly49C and Ly49I NK 
subsets was signifi  cantly impaired in the p110       D910A/D910A   mice, 
we intended to analyze their functional abilities to recognize 
and lyse tumor cells. Toward this, the IL-2  –  activated splenic 
NK cells derived from p110       D910A/D910A   mice were stained 
with anti-Ly49C/I and anti-Ly49G2 mAbs, sorted, and tested 
against EL4  H60  . Because proportions of Ly49C and Ly49I sub-
    Figure 4.         Catalytic inactivation of p110     reduces CD27  High   NK subsets.   BM- (a) or spleen- (b) derived CD3       NK1.1 +   NK cells were analyzed for 
CD11b and CD27 expression. The percentages of CD27  High CD11b Low ,  CD27 High CD11b High  , and CD27  Low CD11b High   cells were calculated. Data are means   ±   SD. 
(c) Alteration in CD27  High   NK subsets correlates with the reduction in Ly49C/I NK subsets. Spleen-derived single-cell suspensions were stained with anti-
NK1.1, anti-CD3     , and each of the indicated anti-Ly49 or CD11b and CD27 mAbs. NK cells as specifi  ed by CD3       NK1.1 +   positivity were gated and analyzed. 
Data shown were obtained using cells from fi  ve to seven mice of each genotype. One representative out of three independent experiments is shown.     JEM VOL. 205, September 29, 2008 
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protein (MIP) 1     , MIP-1     , and regulated upon activa-
tion, normal T cell expressed and secreted (RANTES) (  46  ). 
Therefore, we tested CD3        NK1.1  +   NK cells for cytokine 
generation. Freshly purifi  ed CD3        NK1.1  +   NK cells from 
WT/WT spleens generated an optimal amount of cyto-
kines and chemokines when activated by plate-bound anti-
NKG2D, anti-Ly49D, and anti-NK1.1 mAbs. However, 
NK cells from p110       D910A/D910A   mice were signifi  cantly im-
paired in generating these cytokines and chemokines (  Fig. 6 a  ).   
Thus, the ex vivo  –  purified NK cells that use NKG2D  –
  DAP10 complexes for signaling depend on p110      to gener-
ate cytokine response. Next, we tested the role of p110      
in cytokine and chemokine generation by IL-2  –  activated 
splenic NK cells. As seen in   Fig. 6 b  , WT/WT NK cells 
produced a large amount of IFN-      or GM-CSF when 
stimulated with anti-NKG2D, anti-Ly49D, and anti-NK1.1 
mAbs. However, p110       D910A/D910A   NK cells were severely 
impaired to produce these cytokines. Further, generation 
Clearance of RMA/S versus RMA cells was calculated 
compared with the input ratio, which was normalized to one. 
RMA cells, which are not cleared by either WT/WT or 
p110       D910A/D910A   mice, acted as an internal control. Our results 
show that both WT/WT and p110       D910A/D910A   mice did not 
clear RMA cells. Compared with WT/WT, the ability of the 
p110       D910A/D910A   mice to clear the RMA/S cells was margin-
ally impaired (Fig. S6, a and b, available at http://www
.jem.org/cgi/content/full/jem.20072327/DC1). Comparable 
numbers of NK cells accumulated in the peritoneal cavity of 
both WT/WT and p110       D910A/D910A   mice (Fig. S6, c and d). 
These results confi  rm our in vitro observations and the earlier 
reports on these mice (  45  ). 
  Cytokine/chemokine generation is impaired 
in p110      D910A/D910A   NK cells 
  NK cells can generate infl  ammatory cytokines and chemo-
kines such as IFN-     , GM-CSF, macrophage infl  ammatory 
    Figure 5.         Ex vivo  –   and IL-2  –  activated p110      D910A/D910A   NK cell cytotoxicity are moderately impaired.   (a) Fresh splenic NK cells were purifi  ed 
and used in a 4-h   51  Cr-release assay using EL4  H60   target cells. (b) IL-2  –  activated splenic NK cells were tested against   51  Cr-labeled target cells at the indi-
cated effector/target (E/T) ratios. Cytotoxicity was tested against EL4, EL4  H60  , YAC-1, RMA/S, or CHO cells. Three to fi  ve mice were used for each genotype. 
Open and closed circles represent the mean values from WT/WT and p110     D910A/D910A   mice, respectively. NKG2D-mediated cytotoxic potential of the Ly49C/
I  +   NK subset was more severely impaired compared with Ly49C/I         NK subsets. (c) Ly49C/I  + Ly49G2  ±   , (d) Ly49C/I       Ly49G2 +  , and (e) Ly49C/I       Ly49G2        NK 
subsets were sorted from IL-2  –  activated splenic NK cells derived from WT/WT and p110     D910A/D910A   mice, rested for 12 h, and used in cytotoxicity assays 
with EL4  H60   as target cells. Data presented are means   ±   SD (a and b) or are representative (c  –  e) of at least three independent experiments.   2426 PI3K-P110      REGULATES NK CELL MATURATION AND FUNCTION   | Guo et al. 
and we did not see any preferential reduction in Ly49C/I sub-
sets. This indicates that although p110      regulates both of the ef-
fector functions, it is critically required for cytokine generation. 
To further investigate whether the defect is at the transcrip-
tional level, we quantifi  ed the amounts of IFN-       –  encoding 
mRNA before and after plate-bound anti-NKG2D mAb acti-
vation.   Fig. 8 a   demonstrates a signifi  cantly lower copy number 
of IFN-       –  encoding mRNA in both BM- and spleen-derived 
p110       D910A/D910A   NK cells, indicating a defect at the transcrip-
tional level.   To determine whether this is generalized hypore-
sponsiveness or an exclusive defect associated with YINM- and 
ITAM-containing activation receptors, we stimulated the NK 
cells with IL-12, IL-18, or both in the presence of a suboptimal 
concentration of anti-NKG2D mAb (A10). Interestingly, both 
WT/WT and p110       D910A/D910A  -derived NK cells responded 
equally well to distinct combinations of this activation ( Fig. 8 b ). 
Similar results were obtained using IL-12, IL-18, or both with-
out anti-NKG2D mAb (unpublished data). This demonstrates 
that p110       D910A/D910A   NK cells are fully capable of respond-
ing through their cytokine receptors. 
of the chemokines MIP1-     , MIP1-     , and RANTES from 
p110       D910A/D910A   NK cells was also significantly reduced 
(  Fig. 6 b  ). Similar reductions in the cytokines and chemo-
kines were observed in the BM-derived p110       D910A/D910A   
NK cells (Fig. S7, available at http://www.jem.org/cgi/
content/full/jem.20072327/DC1). This substantial reduc-
tion could be caused by the inability of the p110       D910A/D910A   
NK cells to produce cytokines or simply by a defect in cy-
tokine secretion. To distinguish between these two possibil-
ities, IFN-      production in response to anti-NKG2D mAb 
was measured by intracellular staining. The percentage of 
IFN-       –  positive cells among gated NK1.1  +   populations in 
p110       D910A/D910A   NK cells was signifi  cantly lower compared 
with WT/WT NK cells (P = 0.017;   Fig. 7 a  )   Inactivation of 
p110      reduced the number and functions of NK cells, par-
ticularly, the Ly49C/I subsets. Therefore, to determine the 
cytokine defects in individual Ly49 subsets, we analyzed the 
levels of intracellular IFN-      in each one of them. All of the 
subsets from p110       D910A/D910A   mice generated a signifi  cantly 
less amount of intracellular IFN-      (P   <   0.007;   Fig. 7 b  ), 
    Figure 6.         Ability of ex vivo  –   and IL-2  –  activated p110      D910A/D910A   NK cells to generate cytokines or chemokines is severely impaired.   (a)  10 5  
freshly purifi  ed splenic CD3       NK1.1 +   NK cells per well were activated with plate-bound anti-NKG2D (A10), anti-Ly49D (4D11), or anti-NK1.1 (PK136) mAbs, 
and the supernatants were tested for the indicated cytokines and chemokines in Multiplex assays. (b) 10  5   IL-2  –  activated splenic NK cells per well were 
activated with plate-bound anti-NKG2D (A10), anti-Ly49D (4D11), or anti-NK1.1 (PK136) mAbs, and the resulting supernatants were used in Multiplex 
assays. Data presented are mean values   ±   SD from six mice of each genotype from two independent experiments.     JEM VOL. 205, September 29, 2008 
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p110       D910A/D910A   NK cells in a dose-dependent manner. How-
ever, the inhibition on p110       D910A/D910A   NK cells was signifi  -
cantly less than that on WT/WT NK cells (  Fig. 10 b  ). Blocking 
the function of p38 with its inhibitor, SB202190, had no sig-
nifi  cant eff  ect on NKG2D-mediated lysis of the same target 
  NK-mediated cytokine production requires p110     
during antiinfl  uenza response 
  Infl  uenza virus primarily infects lung epithelial cells that can 
lead to lung pathogenesis. Hence, in this study, we used 
mouse lung epithelial cells (LA4) to characterize the role of 
p110      in NK cytotoxicity and cytokine generation during 
influenza virus infection. We detected the cell-surface ex-
pression of viral HA on LA4 cells (  Fig. 9 a  ) after they were 
infected with PR8, a mouse-adapted human infl  uenza virus.   
A previous study showed that HA functions as a viral ligand 
for NCR1, and its interaction with NCR1 can initiate NK 
cytolysis against PR8-infected 1106mel cells (  21  ). To deter-
mine the role of p110      in regulating the NCR1-mediated 
NK cell recognition of PR8-infected LA4 cells, we first 
compared the WT and p110       D910A/D910A   NK cytotoxicity. 
Co-incubation of WT/WT NK cells with uninfected LA4 
cells led to a basal level of cytotoxicity. PR8 infection of LA4 
cells moderately increased the cytotoxic potentials of WT/
WT NK cells. However, such an increase in the cytotoxicity 
was not observed with p110       D910A/D910A   NK cells (  Fig. 9 b  ). 
Further, direct observations of the lysis of PR8-infected LA4 
in NK/LA4 co-cultures (  Fig. 9 c  ) validated the reduced abil-
ity of the p110       D910A/D910A   NK cells to mediate killing of vi-
rally infected cells. Because NK cells can generate infl  ammatory 
cytokines during viral infection (  46  ), we quantifi  ed these sol-
uble mediators in the supernatants of PR8-infected LA4/NK 
co-cultures. Results presented in   Fig. 9 d   demonstrate that 
although the WT/WT NK cells could produce ample levels 
of IFN-      and GM-CSF, p110       D910A/D910A   NK cells generated 
signifi  cantly lower levels of these two cytokines. Collectively, 
these results for the fi  rst time demonstrate that p110      plays a 
crucial role in the NK cell  –  mediated cytokine generation 
during antiinfl  uenza viral responses. 
  JNK1/2 regulates cytokine generation downstream of p110     
  What are the downstream targets of p110      that regulate the cy-
totoxicity and cytokine gene transcriptions? Earlier studies have 
shown that activation of mitogen-activated protein kinases 
(MAPKs) are required for cytotoxic granule release and cyto-
kine generation in mouse and human NK cells (  47  –  50  ). Also, 
the proposed involvement of p38 and JNK1/2 in regulating 
NK cell eff  ector functions is contentious (  49, 50  ). To identify 
the target molecules downstream of p110     , NK cells were acti-
vated with plate-bound NKG2D mAb, and their lysates were 
analyzed for the activation status of multiple MAPKs. Phos-
phorylation levels of extracellular signal-regulated kinase (ERK) 
1/2 were comparable between the activated WT/WT and 
p110       D910A/D910A   NK cells. p38 phosphorylation is slightly but 
consistently reduced in p110       D910A/D910A   NK cells (  Fig. 10 a  ).   
However, the level of JNK1/2 phosphorylation was signifi  -
cantly reduced in p110       D910A/D910A   NK cells (  Fig. 10 a  ). These 
results indicate that JNK1/2 are major target molecules down-
stream of p110      in NK cells. We confi  rmed the role of JNK1/2 
using a specifi  c pharmacological inhibitor of JNK activation, 
SP600125. Use of this inhibitor signifi  cantly reduced NKG2D-
mediated lysis of EL4  H60   target cells by both WT/WT and 
    Figure 7.         IFN-     generation by p110      D910A/D910A   NK cells were defec-
tive in all Ly49 subsets.   (a) Levels of intracellular IFN-      positivity are sig-
nifi  cantly reduced in p110     D910A/D910A   NK cells. IL-2  –  activated splenic NK cells 
were stimulated with plate-bound anti-NKG2D (A10) mAb for 8 h, com-
bined with Brefeldin A, and incubated for another 4 h. Activated NK cells 
stained for intracellular IFN-     . Cells shown are gated for the CD3       NK1.1 +  
NK population. (b) Levels of intracellular IFN-      positivity in different Ly49 
subsets from WT and p110     D910A/D910A   mice. Percentages of CD3       NK1.1 +   NK 
cells that were positive for intracellular IFN-      are shown with Ly49 markers. 
Data presented are representative of three independent experiments.    2428 PI3K-P110      REGULATES NK CELL MATURATION AND FUNCTION   | Guo et al. 
erate cytokines and chemokines in a dose-dependent manner. 
Conversely, p38 inhibitor only weakly blocked the cytokine 
generation, further confi  rming the crucial role of JNK1/2 in 
cytokine gene transcription. To avoid the nonspecifi  c inhibi-
tion on other kinases, we tested, selected, and used two optimal 
concentrations of JNK1/2 and p38 inhibitors (  51  ). Further, 
cells treated under these concentrations were tested for their vi-
ability using Annexin V and 7-AAD staining, which excluded 
cell death as the reason for our observations (unpublished data). 
Based on these results, we conclude that impairment in the 
JNK1/2 activation is a probable cause for the defect in cytotox-
icity and cytokine generation in p110       D910A/D910A   NK cells. 
    DISCUSSION   
  In this study, we present genetic evidence that unmasks the 
critical functions of PI3K-p110      in NK cells. The important 
role of PI3K in T and B cell development and function has been 
extensively characterized (  28, 29, 32  ). Using p110       D910A/D910A   
mice, we demonstrate that p110      plays a crucial role in NK cell 
terminal maturation and cytokine/chemokine generation. 
  In recent years, multiple   p85   and   p110   gene KO mice 
have been generated (  28, 29, 33, 52, 53  ). Interestingly, in 
these KO mice, altering the expression of one PI3K subunit 
has aff  ected the expression of others. Cells from p85      KO 
mice contained increased levels of p85      and decreased ex-
pression of p110     , p110     , and p110      (  28, 29  ). In contrast, the 
levels of p85      expression were augmented in p110      KO mice 
(  33  ). Some of these mice have been recently used to charac-
terize the development and functions of NK cells. Tassi et al. 
shows a signifi  cant reduction of p85      subunit in NK cells de-
rived from p110      KO mice (  54  ). Also, NK cells from these 
mice have increased expression of p110      and p110      subunits, 
although the p110      expression level was not changed. Re-
cently, another independently generated p110      KO mice 
were used by Kim et al. in a NK cell study (  55  ), and an earlier 
characterization of these mice showed decreased expression of 
p85     , p55     , and p50      subunits in B cells (  52  ). Therefore, in 
this study, we used mice with a point mutation that com-
pletely inactivated the catalytic function of p110      subunit 
without altering the normal expression levels of p110      protein 
(  32  ). More importantly, this strategy did not result in any 
compensatory change in the expression levels of total p85, 
p110     , and p110      subunits in thymocytes (  32  ). In the present 
study, we show that both BM- and spleen-derived NK cells 
from p110       D910A/D910A   mice did not have any alteration in the 
levels of either p110      or other p110 subunits. Further, there 
were no changes in the levels of total p85 or p85      subunits. 
These results are in line with our earlier observations (  32  ). 
However, one of the major concerns in introducing a single 
amino acid change in p110      protein is its possible dominant 
negative eff  ect. Our earlier fi  ndings demonstrated a diff  eren-
tial sensitivity of distinct receptor systems after p110      in-
activation in p110       D910A/D910A   mice (  56  ). For example, PI3K 
signaling via c-kit and Fc     RI receptors was almost fully abol-
ished in p110       D910A/D910A   mast cells; this is in contrast to PI3K 
(Akt/protein kinase B) signaling induced by IL-3, which was 
cells (  Fig. 10 b  ). To determine their role in cytokine genera-
tion, we blocked JNK1/2 and p38 and assayed the ability of 
NK cells to respond to anti-NKG2D mAb  –  mediated stimula-
tion.   Fig. 10 c   shows that inhibiting JNK function abolished the 
ability of both WT/WT and p110       D910A/D910A   NK cells to gen-
    Figure 8.         Defect in cytokine production occurs at the transcrip-
tional level, and IL-12/IL-18  –  mediated generation of cytokine/che-
mokine is intact in p110      D910A/D910A   NK cells.   (a)   IFN-    – encoding  mRNA 
levels were reduced in p110     D910A/D910A   NK cells. NK cells were stimulated 
with anti-NKG2D mAb for 6 h, and mRNA was extracted and   IFN-    – encod-
ing transcripts were quantifi  ed. (b) NK cell cytokine and chemokine pro-
duction upon stimulation with a suboptimal concentration of anti-NKG2D 
mAbs in the presence or absence of IL-12, IL-18, or both. Data presented 
are means   ±   SD and are representative of three independent experiments.     JEM VOL. 205, September 29, 2008 
ARTICLE
2429
activity of p110      is dispensable for the early NK cell develop-
ment. In addition, earlier studies from us and others showed 
that a lack of phospholipase C      2 did not alter the numbers of 
CD122  +   NKPs (  59  –  61  ). Thus, it appears that neither p110      
nor phospholipase C      2 are needed for the commitment of 
early progenitors into NK lineage. In the second developmen-
tal stage, NKPs acquire NK1.1, NKG2D, and CD94/NKG2A/
C/E in a sequential developmental process (  34  ). The start of 
the expression of integrins such as CD49b and CD51 is also 
part of this second stage (  34, 58  ). Normal expressions of these 
markers by p110       D910A/D910A   NK cells in the BM and spleen 
demonstrate that NK maturation is not hindered at this stage. 
  Mature mouse NK cells are defi  ned by the expression of 
one or more Ly49 receptors. Terminal maturation of NK cells 
is initiated by a decrease in the expression of CD51, active pro-
liferation, and a concomitant increase in the levels of both 
CD11b and CD43 (  34  ). At this stage, the   “  immature  ”   NKPs 
start acquiring diff  erent Ly49s (  58  ). Analyses of Ly49 expression 
only partially blocked (  56  ). The remaining PI3K signaling 
downstream of the IL-3 receptor could be fully blocked by 
broad-spectrum PI3K inhibitors (  56  ), indicating that kinase-
dead p110      does not exert a dominant-negative function. 
Thus, a knock-in mouse with a point mutation in p110      that 
abolishes its kinase function but not its protein expression pro-
vides an exclusive system to delineate the precise functions of 
PI3K in NK cells. 
  Using p110       D910A/D910A   mice, we first determined the 
development and maturation of NK cells. Common lymphoid 
progenitors that give rise to T, B, and NK cells have been 
found in the BM (  57  ). Committed NK precursors (NKPs), 
which exclusively mature into NK cells, have been identifi  ed 
in the fetal thymus and in adult BM (  58  ). This earliest develop-
mental stage of NKPs is defi  ned by the expression of CD122. 
Thus, the expression of CD122 uniquely marks the committed 
NKPs (  35  ). The expression of CD122 in p110       D910A/D910A   NK 
cells is comparable to that of WT, indicating that the catalytic 
    Figure 9.         NK cells from p110      D910A/D910A   mice have a decreased ability to mediate cytotoxicity and produce cytokines against infl  uenza virus 
infection.   (a) LA4 cells were infected with PR8 at an MOI of 0.05. 24 h after infection, expression of HA was quantifi  ed using anti-HA mAb by fl  ow cytom-
etry. (b) Recognition of PR8-infected LA4 cells by p110     D910A/D910A   NK cells is impaired. LA4 was infected with PR8 at an MOI of 0.05 for 24 h, labeled with 
  51  Cr, and used for cytotoxicity assays. Data presented are the mean values from three WT/WT and p110     D910A/D910A   mice, respectively. (c) p110     D910A/D910A   NK 
cells have severely impaired ability to lyse infected LA4 cells, as shown by direct observation of cytolysis. LA4 cells were infected with PR8 at an MOI of 
0.05 for 1 h, and NK cells were added and co-cultured for 8 h. Lysis of the infected LA4 monolayer was observed under light microscopy and recorded 
with a mounted camera. Bars, 12   μ  m. (d) p110     D910A/D910A   NK cells generate signifi  cantly lower levels of cytokines when co-cultured with PR8-infected LA4 
cells. Generation of IFN-      and GM-CSF was quantifi  ed in the supernatants of PR8-infected LA4/NK cell co-cultures collected at 24 h after infection. Data 
presented were either one representative or means, and mean values of three to fi  ve experiments.     2430 PI3K-P110      REGULATES NK CELL MATURATION AND FUNCTION   | Guo et al. 
observed variations in the results. Recent studies indicated that 
the mature CD11b  +   NK cells can be further subdivided into 
CD27  High   and CD27  Low   (  39  ). This study demonstrated that 
CD27  High   NK cells were superior in their ability to lyse target 
cells and generated considerably higher amounts of IFN-      
compared with those of CD27  Low   cells. 
  Reduction in the Ly49C and Ly49I NK subsets in 
p110       D910A/D910A   mice needs further evaluation. Gene deletion 
of another lipid phosphatase,   PTEN  , whose major substrate is 
phosphatidylinositol (3,4,5)-triphosphate, leads to an increased 
Ly49C and Ly49I expression in NKT cells (  62  ). Interestingly, 
this abnormal increase of Ly49C or Ly49I in NKT cells from 
  PTEN   KO mice was reversed by backcrossing the   PTEN  -de-
fi  cient mice with p110       D910A/D910A   mice (  62  ). Collectively, our 
on p110       D910A/D910A   NK cells indicated an exclusive reduction 
in Ly49C and Ly49I subsets. Other NK subsets, such as Ly49A, 
Ly49G2, and Ly49D were normal. Recently, Tassi et al. has 
used p110     , p110     , or p110     /      double KO mice to determine 
the NK cell development and function (  54  ). These studies 
showed reductions in Ly49A and Ly49C/I subsets in p110      
and p110     /p110      double KO mice; however, no changes 
were observed in Ly49C/I NK subsets in p110      KO mice. 
Conversely, Kim et al., using independently generated KO 
mice, dem  onstrated small reductions in the Ly49C/I in 
p110      KO mice and Ly49G2 in p110      KO mice (  55  ). The 
p110       D910A/D910A   mice used in the present study and one of the 
two p110      KO mice are of the C57BL/6 background. This 
suggests that strain diff  erences in mice did not account for the 
    Figure 10.         JNK1/2 regulates cytotoxicity and cytokine generation downstream of p110    .   (a) IL-2  –  cultured NK cells were stimulated with plate-
bound anti-NKG2D mAb for the indicated times. Phosphorylation of ERK1/2, JNK1/2, and p38 was detected by Western blotting. One representative experi-
ment out of three is shown. (b) Inhibition of cytotoxicity against EL4  H60   by p38 inhibitor(SB 202190) or JNK1/2 inhibitor (SP600125). (c) Inhibition of 
cytokine/chemokine generation upon stimulation with plate-bound anti-NKG2D mAb by p38 inhibitor (SB 202190) or JNK1/2 inhibitor (SP600125). Data 
presented in b and c were means   ±   SD obtained from three mice of each genotype. Data shown were obtained from three to fi  ve independent experiments.     JEM VOL. 205, September 29, 2008 
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main of JNK1 and JNK2 needs combined stimulation through 
TCR and CD28 together; alone, each stimulus resulted in lit-
tle or no eff  ect (  70  ). Our data indicate that JNK1/2 are critical 
downstream eff  ectors of P110     , and that they could regulate 
cytokine gene transcription and cytotoxic granule release. 
These fi  ndings are in line with the recent observations in an 
NKG2D-expressing human NKL cell line, where inhibition 
of JNK activity resulted in the impaired movement of micro-
tubule organizing center, granzyme B, and paxillin to the im-
mune synapse (  49  ). Several transcription factors as substrates 
have been described for JNK1/2, including activator protein 
1 (  71  ). Evidence for this is provided by the activator protein 
1  –  dependent cytokine gene transcription in Fc     RIIIA-stimu-
lated human NK cells (  72  ). In conclusion, our current obser-
vations establish a strong basis to further explore PI3K-mediated 
novel NK cell cytokine generation pathways. 
  NK cells can clear an intracellular infection either by di-
rect killing of the infected cells or through the release of cy-
tokines, e.g., IFN-     . It has been demonstrated that NK cells 
can recognize and kill infl  uenza virus  –  infected cells through 
the interaction of NCR1 with viral HA (  21  ). Further, func-
tional loss of NCR1 caused lethal infl  uenza virus infection in 
a mouse model (  73  ). However, the signaling pathway gov-
erning NCR1-mediated activation has not been investigated. 
Infl  uenza virus primarily target respiratory cells. Mouse lung 
epithelial cells (LA4) can be infected with PR8 and express 
viral HA. p110       D910A/D910A   NK cells showed reduced lysis 
against PR8-infected cells, which indicates the involvement 
of p110      in NCR1-mediated cytotoxicity. Most signifi  -
cantly, the p110       D910A/D910A   NK cells were impaired in their 
ability to produce IFN-      and GM-CSF upon recognition of 
PR8-infected LA4, confi  rming the importance of p110      in 
antiviral immunity. Replication of high pathogenic infl  uenza 
infection usually peaks within 5 d (  74  ). Controlling fl  u infec-
tion during this short time window currently relies on antifl  u 
drugs and vaccines, which usually are not eff  ective for virulent 
infl  uenza virus. Our results suggest an alternative approach to 
control emerging pandemic infl  uenza infection by boosting 
the NK cell eff  ector functions through potential drugs specif-
ically targeted to signaling molecules. 
  MATERIALS AND METHODS 
  Mice and cell lines.     Generation of PI3K-p110       D910A/D910A   mice was previ-
ously described (  30  ). PI3K-p110       D910A/D910A   mice used in the present study 
were backcrossed to C57BL/6 for N12/N13 generations. The mutant and 
C57BL/6 (WT/WT) mice were maintained in pathogen-free conditions at 
the Biological Resource Center (BRC) of the Medical College of Wisconsin 
(MCW). All of the animal protocols used were approved by the Institutional 
Animal Care and Use Committee, BRC, MCW. Target cells (EL4, EL4  H60  , 
RMA/S, and YAC-1) and their culture conditions were previously de-
scribed (  35  ). CHO cells were cultured similarly to other target cells. Madin-
Darby canine kidney (MDCK) cells and a mouse lung epithelial cell line 
(LA4) were purchased from the American Type Culture Collection and 
were cultured in RPMI 1640 medium with 10% or 15% FBS, respectively. 
  Virus and viral infections.     Mouse-adapted human infl  uenza virus A/PR8 
(H1N1) was obtained from T. Moran (Mount Sinai School of Medicine, 
New York, NY). Infl  uenza virus stocks were propagated in MDCK cells, 
and titers were determined by a plaque-forming assay. 
fi  ndings in the reduction of Ly49C and Ly49I expression pre-
dict a key role for p110      in the dynamic interaction between 
PI3K, phosphatidylinositol (3,4,5)-triphosphate, lipid phos-
phatases, and inhibitory Ly49 receptors. 
  NK cells can kill tumor cells without prior sensitization. To 
study the role of p110      in lytic signaling, we used diff  erent tu-
mor cells representing self, induced-self, and missing-self. Lack 
of p110      moderately aff  ected the antitumor responses against 
these target cells. This marginal impairment in cytotoxicity 
could be caused by the reduction in the CD27  High   NK subsets 
in p110       D910A/D910A   mice, because this subset has been demon-
strated to play a dominant role in cytotoxic granule release (  39  ). 
NK cells generate infl  ammatory cytokines and chemokines as 
part of innate immunity. Previous studies demonstrated a lack 
of DAP12 or Syk/ZAP70 but not DAP10, severely impairing 
NKG2D-mediated cytokine production (  7, 11, 63  ). In con-
trast, a signifi  cant reduction in cytokine generation mediated 
via NKG2D and Ly49D was observed in p110       D910A/D910A   NK 
cells. Further, similar reductions were also observed when 
p110       D910A/D910A   NK cells were activated via the NK1.1 recep-
tor that uses FcR      to mediate its signal (  24  ). These results sug-
gest that p110      plays a pivotal role in the cytokine generation 
by NK cells. Earlier studies have demonstrated that CD-
27  High  CD11b  High   NK cells generated IFN-      in response to 
NKG2D-mediated stimuli (  39  ). Thus, a signifi  cant decline in 
the CD27  High   NK cells in p110       D910A/D910A   mice provides ad-
ditional cellular explanations for the reduction in cytokine gen-
eration. The proinfl   ammatory cytokines IL-12 and IL-18, 
derived from monocytes, can induce IFN-      generation in NK 
cells (  64  ). In combinations, IL-12 and IL-18 can mediate sig-
naling events that are distinct from those of YINM- or ITAM-
containing receptor-mediated activations. Stimulation with 
IL-12 and IL-18, along with a suboptimal concentration of 
anti-NKG2D mAb, resulted in comparable levels of IFN-     , 
GM-CSF, MIP-1     , MIP-1     , and RANTES between WT/
WT and p110       D910A/D910A   NK cells. Compared with p110      
KO NK cells (  55  ), we did not observe any increased produc-
tion of IFN-      upon IL-12 and IL-18 stimulation. We con-
clude that ITAM-independent pathways are fully operational 
in p110       D910A/D910A   NK cells. An explanation for this observa-
tion comes from the comparable levels of p38 phosphorylation 
between WT/WT and p110       D910A/D910A   NK cells, which is 
crucial for the generation of cytokines downstream of IL-12/
IL-18 receptors (  65, 66  ). 
  MAPKs are potential downstream targets for multiple ac-
tivation receptors, including NKG2D (  67  ). MAPKs are ser-
ine-threonine kinases with a T-X-Y motif in their cytoplasmic 
domain, and they regulate multiple immune cell eff  ector func-
tions (  68  ). The MAPK family includes ERK1/2, JNK1/2, 
and p38. The regulatory roles of these MAPKs in NK func-
tions are emerging (  47  –  50, 67, 69  ). ERK1/2 can be activated 
by multiple mitogenic stimuli; however, JNK1/2 and p38 are 
activated by stress-inducing agents or proinfl  ammatory cyto-
kines. Earlier studies using T cells have provided evidence for 
the role of PI3K in JNK activation (  70  ). In T cells, full activa-
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gels and transferred to polyvinylidene fl  uoride membranes. The blot was probed 
with the mAbs indicated in the fi  gures.  Anti  –  rabbit PI3K-p110     , p110     , 
p110     , and p110     , and anti  –  mouse PI3K-p85      mAbs were purchased from 
Santa Cruz Biotechnology, Inc. Pan  –  anti  –  PI3K-p85 mAb was obtained from 
Millipore, and anti  –       -actin mAb was from Boehringer Mannheim. After incu-
bation with either horseradish peroxidase  –  conjugated anti  –  rabbit or anti  –  mouse 
mAbs (Santa Cruz Biotechnology, Inc.), membranes were washed and signals 
were detected using an enhanced chemiluminescence kit (GE Healthcare). 
  MAPK activation.     Cultured NK cells were serum starved for 2 h in PBS 
and stimulated with plate-bound anti-NKG2D mAb for the time indicated 
in the fi  gure. Cells were lysed directly in the 96-well plate by the ad-
dition of 1   ×   RIPA buff  er (Boston BioProducts) containing protease in-
hibitors and phosphatase inhibitor cocktails (EMD). Lysates were analyzed 
for phospho-p38 (Thr180/Tyr182), phospho-ERK1/2 (Thr202/Tyr204), 
phospho-JNK1/2 (Thr183/Tyr185), respective total proteins, and      -actin 
(Cell Signaling Technology) by Western blotting. 
  Cytokine and chemokine quantifi  cation.     Fresh or IL-2  –  cultured, Fc-
blocked NK cells were activated with titrated concentrations of plate-bound 
anti-NKG2D (A10), anti-Ly49D (4E5), and anti-NK1.1 (PK136) mAbs. 
Where indicated in the fi  gures, NK cells were activated with 2.5 ng/ml IL-
12 and 2.5 ng/ml IL-18, or both, in the presence (  Fig. 9  ) or absence (not 
depicted) of anti-NKG2D mAb (A10). IFN-     , GM-CSF, MIP-1     , MIP-
1     , and RANTES were quantifi  ed using Multiplex kit (Bio-Rad Labora-
tories). Intracellular cytokines were quantifi  ed using established methodologies 
(  75  ). In brief, NK cells were activated with 10   μ  g/ml of plate-bound anti-
NKG2D (A10) mAb for 12 h in the presence of Brefeldin A for the last 4 h 
of activation. Activated NK cells were Fc-blocked; stained for NK1.1 alone 
or in combination with anti-Ly49A, -Ly49D, -Ly49C/I, -Ly49I, or 
-Ly49G2 mAbs; fi  xed; permeabilized; and quantifi  ed for intracellular IFN-      
using FITC- (eBioscience) or PE- (BD Biosciences) conjugated anti  –  IFN-      
mAbs through fl  ow cytometry. For   IFN-       encoding mRNA quantifi  cation, 
NK cells were activated for 6 h and harvested for RNA extraction using the 
RNeasy Mini Kit (QIAGEN).   IFN-       real-time PCR was performed by 
using a previously published SYBR green protocol with a thermal cycler 
(model 7900HT; Applied Biosystems) (  76  ). The transcript in each sample 
was assayed in triplicate, and the mean cycle threshold was used to calculate 
the   x  -fold change and control changes for each gene. Three housekeeping 
genes were used for global normalization in each experiment (  Actin  ,   Rps11  , 
and   Tubulin  ). Data validity by modeling of reaction effi   ciencies and analysis 
of measurement precision was determined as described previously (  76  ). 
Primer sequences for   IFN-       were 5     -GACTGTGATTGCGGGGTTGT-3      
(sense) and 5     -GGCCCGGAGTGTAGACATCT-3      (antisense). 
  Drug inhibition assay.     p38 and JNK specifi  c inhibitors SB 202190 and 
SP600125 (Sigma-Aldrich) were dissolved in DMSO and used in a cytotox-
icity assay with   51  Cr-labeled EL4  H60   or a cytokine stimulation assay using 
plate-bound anti-NKG2D mAb. Starting concentrations for inhibitors were 
20   μ  M, based on the kinase activity curve (  51  ). In brief, cultured NK cells 
were harvested and seeded into 96-well plates at 10  5   cells for the cytotoxicity 
inhibition assay. Before incubation with target cells, NK cells were treated 
with SB 202190 or SP600125 for 1 h at 37  °  C, washed, and combined with 
target cells in a 4-h cytotoxicity assay. For cytokine stimulation, 2   ×   10  5   NK 
cells/well were seeded directly into 96-well plates that were precoated with 
anti-NKG2D mAb, followed by the addition of SB 202190 and SP600125 
inhibitors. Plates were incubated for 1 h at 37  °  C, washed, and added with 
200   μ  l RPMI 1640 with 10% FBS per well in an 18-h stimulation assay. Po-
tential apoptosis caused by both inhibitors at each concentration was tested 
by 7-AAD and Annexin V staining. 
  Statistics.     Statistical analysis was performed with the two-tailed, unpaired 
Student  ’  s   t   test using Microsoft Excel 2003 software to compare the diff  er-
ences between WT/WT and PI3K-p110       D910A/D910A   mice. P   ≤   0.05 was 
considered signifi  cant. 
  NK cell preparation.     NK cells were purifi  ed as previously described (  35  ). 
In brief, single-cell suspensions from spleen and BM were passed through 
nylon wool columns to deplete adherent populations consisting of B cells 
and macrophages. Nylon wool  –  nonadherent cells were cultured with 1,000 
U/ml of IL-2 (NCI BRB Preclinical Repository). Purity of the NK cultures 
was checked, and preparations with   >  90% NK1.1  +   cells were used. Alterna-
tively, for ex vivo assays, NK cells were purifi  ed with DX5 mAb (eBiosci-
ence) by magnetic sorting according to manufacture  ’  s protocol. Purify of 
NK cells was usually     80%. 
  Co-culture assays.     2.5   ×   10  5   LA4 cells per well were seeded in 24-well 
tissue culture plates overnight. Cells were washed twice and inoculated with 
PR8 at a multiplicity of infection (MOI) of 0.05. After a 1-h incubation at 
37  °  C, the inoculum was removed and LA4 cells were washed twice, fol-
lowed by the addition of IL-2  –  activated splenic NK cells at the ratios indi-
cated in the fi  gures. Supernatants were collected at the times indicated in 
the fi  gures for cytokine quantifi  cation. 
  Flow cytometry.     Cell preparations were stained with fl  uorescent-labeled 
mAbs, as previously described (  75  ). mAbs for NK1.1 (PK136), CD3      (145-
2C11), NKG2D (A10), NKG2A (16a11), CD43 (1B11), CD49b (DX5), 
CD51 (RMV-7), CD69 (H1.2F3), CD122 (5H4), CD11b (M1/70), CD27 
(LG.7F9), and Ly49I (YLI-90) were obtained from eBioscience. mAbs for 
CD244 (2B4), Ly49A (A1), Ly49D (4E5), Ly49C/I (5E6), and Ly49G2 
(4D11) were obtained from BD Biosciences. mAbs for mouse H-2K  b   and 
H-2D  b   were obtained from Invitrogen. Antibody for infl  uenza HA (IVC102) 
was obtained from GeneTex, Inc. A standard fl  ow cytometry analysis was 
performed using an LSR II with FACSDiva software (Becton Dickinson). 
IL-2  –  activated splenic NK cells derived from p110       D910A/D910A   mice were 
also stained with Ly49C/I (5E6) and Ly49G2 (4D11) mAbs and subjected to 
cell sorting using a FACSAria (Becton Dickinson). Cytotoxicity of sorted 
NK subsets was tested against EL4  H60   (see the following section). 
  Cytotoxicity assays.     NK-mediated cytotoxicity was quantifi  ed using   51  Cr-
labeled target cells, including EL4, EL4  H60  , RMA/S, YAC-1, CHO, and 
PR8-infected and noninfected LA4 cells at varied eff  ector/target  ratios. 
Anti-NKG2D mAb C7 (eBioscience) were used at the concentrations indi-
cated in the fi  gures to block the recognition of H60 on EL4  H60   through the 
NKG2D receptor. The percentage of specifi   c lysis was calculated using 
amounts of absolute, spontaneous, and experimental   51  Cr release from target 
cells. For the in vivo tumor clearance assay, RMA and RMA/S cells were 
labeled with 0.1   μ  M CFSE and 0.2   μ  M SNAF (Invitrogen), respectively, for 
10 min and were quenched with 10% FBS 1640 medium. Cells were mixed 
at a concentration of 10   ×   10  6   cells/ml of each in PBS, and 400   μ  l was in-
jected intraperitoneally into each mouse. Peritoneal exudate was collected 
6 h later, and the fl  uorescence of single-cell suspensions was analyzed by 
fl  ow cytometry. The ratio of RMA/S to RMA cells was calculated. NK cells 
in the cell suspensions were analyzed by staining with anti-CD3 and anti-
NK1.1 mAbs. A dye swap was also performed. 
  NK cell proliferation.     Splenic NK cells were cultured for 6 d, harvested, 
seeded into a 6-well plate (2   ×   10  6   cells/well), and incubated for 2 h. BrdU 
was then added to a fi  nal concentration of 10   μ  M, and cells were further incu-
bated for 4 h, after which cells were stained with anti-CD3, -NK1.1, -Ly49A, 
-Ly49C/I, and -Ly49G2 mAbs for 30 min on ice, washed, and fi  xed with 1% 
paraformaldehyde  –  0.01% Tween-20 in PBS at 4  °  C for 20 min. Cells were 
washed and resuspended in permeabilization buff   er containing 50 Kunitz 
DNase I/ml and incubated for 30 min at 37  °  C. After the wash, cells were fi  -
nally stained with anti  –  BrdU-FITC (BD Biosciences). For apoptosis analysis, 
6-d IL-2  –  activated NK cells were stained with FITC-conjugated mAbs for 
Ly49A, Ly49D, Ly49C/I, and Ly49G2; washed; and stained with 7-AAD and 
Annexin V  –  PE (BD Biosciences), according to manufacturer  ’  s protocol. 
  Western blotting.     Immunoblots of PI3K-p110 isoforms in NK cells were 
performed. In brief, 10  6   NK cell lysates were resolved using 10% SDS-PAGE JEM VOL. 205, September 29, 2008 
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